About Ritu Shah
Form D filings for Moonlight Therapeutics in 2024 list Ritu Shah as director.
Ritu Shah first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ritu Shah in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ritu Shah works with at each company, as listed on that company's latest Form D.
Moonlight Therapeutics Inc. · Form D, Aug 16, 2024